Torsemide
Torsemide is a loop diuretic (water pill) used to treat fluid buildup (edema) from heart failure, kidney disease, or liver disease, and to lower high blood pressure.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 34 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Torsemide is a loop diuretic (a “water pill”) that makes the kidneys pass extra salt and water into the urine, treating swelling from heart failure, kidney disease or liver disease and lowering high blood pressure; on the market since about 1993 and available as a generic, it is a common once-daily alternative to furosemide. Most people tolerate it well; mainly you notice more trips to the bathroom for some hours after each dose. Too much fluid or potassium loss is the main risk, so report dizziness, cramps or muscle weakness, or ringing in the ears or hearing change, and expect regular blood tests for potassium, sodium and kidney function.
Clinical pearls
- Take it in the morning so the extra urination ends before bed; food slightly delays it without weakening it.
- Skip ibuprofen and naproxen when you can; they blunt torsemide and strain the kidneys, and acetaminophen is usually safer.
- If you take lithium, make sure that prescriber knows about torsemide, since it pushes lithium levels toward toxicity.
- With heart failure, weigh yourself each morning; a quick gain often means fluid is returning, so do not stop torsemide on your own.
Patient information guide A plain-language walkthrough of Torsemide, written from its FDA label.
What Torsemide is used for
▾
Torsemide is a loop diuretic approved for two main categories of use across its supported products:
- Edema (fluid buildup) due to heart failure — helps the body shed excess fluid that accumulates from a failing heart
- Edema due to renal disease (kidney disease) — reduces swelling caused by the kidneys' impaired ability to manage fluid
- Edema due to hepatic disease (liver disease, including cirrhosis with ascites) — reduces fluid retention, though extra precautions apply in liver disease
- High blood pressure (hypertension) — lowers blood pressure to reduce the risk of stroke and heart attack; can be used alone or with other blood pressure medications
How Torsemide works
▾
Torsemide works deep inside the kidneys, at a section of the kidney tubule called the loop of Henle. It blocks a specific transport channel (the Na⁺/K⁺/2Cl⁻ carrier) that normally pulls sodium, chloride, and water back into the body. When that channel is blocked, those substances stay in the urine and get flushed out — taking extra fluid with them. This is why torsemide is called a loop diuretic, or water pill.
Importantly, torsemide does not significantly affect overall kidney filtration rate or the body's acid-base balance at normal doses, which makes it useful even in people with some degree of kidney disease.
Torsemide dosage
▾
Torsemide tablets are taken once daily by mouth. They can be taken with or without food — eating at the same time may slightly delay the onset of effect but does not change how well the drug works overall. Because it increases urination, most people take it in the morning to avoid disrupted sleep.
- For edema, your doctor will start you at a lower dose and may gradually increase it if needed
- For liver disease (cirrhosis), torsemide should be taken alongside a potassium-protecting medication as your doctor directs
- For high blood pressure, the full effect may take up to 4–6 weeks, and sometimes up to 12 weeks
Always follow your prescriber's specific instructions. Do not stop taking it suddenly without talking to your doctor first.
Dosing details from the FDA-approved label
From the Torsemide prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Edema associated with heart failure
- Initial dose is 10 mg or 20 mg once daily
- If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained
- Maximum: Doses higher than 200 mg have not been adequately studied
- Edema associated with chronic renal failure
- Initial dose is 20 mg once daily
- If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained
- Maximum: Doses higher than 200 mg have not been adequately studied
- Edema associated with hepatic cirrhosis
- Initial dose is 5 mg or 10 mg once daily, administered together with an aldosterone antagonist or a potassium-sparing diuretic
- If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained
- Maximum: Doses higher than 40 mg have not been adequately studied in this population
- Given together with an aldosterone antagonist or a potassium-sparing diuretic
- Hypertension
- Initial dose is 5 mg once daily
- If the 5 mg dose does not provide adequate reduction in blood pressure within 4 to 6 weeks, increase to 10 mg once daily
- If the response to 10 mg is insufficient, add another antihypertensive agent
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Edema associated with: Heart failure: Initial dose is 10 or 20 mg once daily. Titrate by factors of two; doses above 200 mg have not been studied. (2.1) Chronic Renal Failure: Initial dose is 20 mg once daily. Titrate by factors of two; doses above 200 mg have not been studied.(2.1) Hepatic Cirrhosis: Initial dose is 5 or 10 mg once daily. Titrate by factors of two; doses above 40 mg have not been studied. (2.1) Hypertension: The recommended initial dose is 5 mg once daily. After 4 to 6 weeks, increase to 10 mg once daily, if needed. If 10 mg is insufficient, consider adding another agent. (2.2) 2.1 Treatment of Edema Edema associated with heart failure The recommended initial dose is 10 mg or 20 mg oral torsemide tablets once daily. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 200 mg have not been adequately studied. Edema associated with chronic renal failure The recommended initial dose is 20 mg oral torsemide tablets once daily. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 200 mg have not been adequately studied. Edema associated with hepatic cirrhosis The recommended initial dose is 5 mg or 10 mg oral torsemide tablets once daily, administered together with an aldosterone antagonist or a potassium-sparing diuretic. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 40 mg have not been adequately studied in this population. 2.2 Treatment of Hypertension The recommended initial dose is 5 mg once daily. If the 5 mg dose does not provide adequate reduction in blood pressure within 4 to 6 weeks, increase to 10 mg once daily. If the response to 10 mg is insufficient, add another antihypertensive agent to the treatment regimen.
2.1 Treatment of Edema Edema associated with heart failure The recommended initial dose is 10 mg or 20 mg oral torsemide tablets once daily. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 200 mg have not been adequately studied.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Torsemide side effects
▾
The most common side effect is excessive urination, which is expected with a diuretic. Other side effects to be aware of include:
Common side effects
- Excessive urination (most common)
- Low potassium levels (hypokalemia) — may cause muscle cramps or weakness
- Low sodium levels (hyponatremia)
- Increased blood sugar (hyperglycemia)
- Small increases in uric acid (may rarely trigger gout)
- Small increases in cholesterol and triglycerides (with higher doses, usually temporary)
- Nausea or loss of appetite (reported after approval)
- Low sodium or magnesium levels
- Small increases in uric acid — rarely can trigger a gout attack
- Dizziness or lightheadedness, especially when standing up
When to get medical help
- Call your doctor if you feel dizzy, faint, or lightheaded — this may signal low blood pressure or dehydration
- Get medical help if you have significantly decreased urination or signs of worsening kidney function
- Tell your doctor right away if you notice ringing in your ears (tinnitus) or any hearing loss
- Seek care immediately for a severe skin reaction such as blistering, peeling, or widespread rash (rare but serious)
- Contact your doctor if you develop signs of very low potassium — muscle weakness, cramps, or irregular heartbeat
- People with liver disease (cirrhosis): watch for confusion or worsening mental status, which could signal hepatic encephalopathy
Call your doctor right away if you experience signs of severe dehydration, significant hearing changes, a serious skin reaction (blistering or peeling), or symptoms of dangerously low electrolytes like muscle weakness or irregular heartbeat.
Torsemide warnings and precautions
▾
- Dehydration and low blood pressure: Too much diuresis can cause dehydration and a dangerous drop in blood pressure, especially in people who are already low on salt or taking ACE inhibitors or ARBs. Kidney function can worsen as a result.
- Electrolyte imbalances: Torsemide can lower potassium, sodium, magnesium, and calcium. It can also raise blood sugar and uric acid. Routine lab monitoring is important.
- Hearing problems (ototoxicity): Ringing in the ears or hearing loss has been reported — usually reversible, but the risk goes up with high doses, severe kidney problems, or when combined with other ear-damaging drugs.
- Liver disease caution: In people with cirrhosis, sudden fluid and electrolyte shifts can trigger hepatic encephalopathy (brain confusion caused by liver failure). Diuresis in these patients is best started in a hospital setting.
Torsemide interactions
▾
Torsemide interacts with several medications — always tell your prescriber and pharmacist everything you take:
- NSAIDs (e.g., ibuprofen, naproxen): Reduce torsemide's effectiveness and significantly increase the risk of kidney damage
- Lithium: Torsemide reduces how fast the kidneys clear lithium, raising the risk of lithium toxicity — blood levels should be monitored
- ACE inhibitors / ARBs (common blood pressure drugs): Combining with torsemide raises the risk of low blood pressure and kidney problems
- Aminoglycoside antibiotics (e.g., gentamicin): Greatly increases the risk of hearing damage — avoid this combination if possible
- Warfarin / phenytoin: Torsemide inhibits a liver enzyme (CYP2C9) that processes these drugs — levels may be affected and need monitoring
- CYP2C9 inhibitors (e.g., fluconazole, amiodarone, miconazole): Can raise torsemide concentrations in the blood
- Cholestyramine: Can reduce absorption of torsemide — take torsemide at least 1 hour before or 4–6 hours after cholestyramine
- Corticosteroids / ACTH: Increase the risk of potassium dropping too low
Interactions listed in the FDA-approved label
From the Torsemide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Non-steroidal anti-inflammatory drugs (NSAIDs) and salicylates: NSAIDs can reduce the antihypertensive and diuretic effects of torsemide and have been associated with acute renal failure; patients receiving high doses of salicylates may experience salicylate toxicity
- CYP2C9 inhibitors (e.g., amiodarone, fluconazole, miconazole, oxandrolone) and inducers (e.g., rifampin): Inhibitors can decrease torsemide clearance and increase plasma concentrations; inducers increase clearance and decrease plasma concentrations Monitor diuretic effect and blood pressure when used with a CYP2C9 inhibitor or inducer. Adjust torsemide dose if necessary.
- Sensitive CYP2C9 substrates (e.g., celecoxib) or narrow therapeutic range substrates (e.g., warfarin, phenytoin): Torsemide may affect the efficacy and safety of these drugs because of its inhibition of CYP2C9 metabolism Monitor patients and adjust dosages if necessary.
- Cholestyramine: In an animal study, cholestyramine decreased the absorption of orally administered torsemide; concomitant use has not been studied in humans If coadministered, administer torsemide at least one hour before or 4 to 6 h after cholestyramine.
- Organic anion drugs (e.g., probenecid): May reduce secretion of torsemide into the proximal tubule and thereby decrease the diuretic activity of torsemide Monitor diuretic effect and blood pressure during coadministration.
- Lithium: Torsemide reduces the renal clearance of lithium, inducing a high risk of lithium toxicity Monitor lithium levels periodically when torsemide is coadministered.
- Ototoxic drugs (aminoglycoside antibiotics, ethacrynic acid): Loop diuretics increase the ototoxic potential of other ototoxic drugs; reported with torsemide and gentamycin Avoid concomitant use of torsemide and aminoglycoside antibiotics, if possible.
- Renin angiotensin inhibitors (ACE inhibitors, angiotensin receptor blockers): Can increase the risk of hypotension and renal impairment
- Radiocontrast agents: Torsemide can increase the risk of renal toxicity related to radiocontrast agents
- Corticosteroids and ACTH: Concomitant use may increase risk of hypokalemia
Read the label’s full interactions text
7 DRUG INTERACTIONS Non-steroidal anti-inflammatory drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects; risk of renal impairment. (7.1) CYP2C9: Concomitant use with CYP2C9 inhibitors can decrease torsemide clearance. Torsemide may affect the efficacy and safety of sensitive CYP2C9 substrates or of substrates with a narrow therapeutic range, such as warfarin or phenytoin. (7.2) Cholestyramine: Decreased exposure of torsemide. (7.3) Organic anion drugs: may decreae diuretic activity of torsemide. (7.4) Lithium: Risk of lithium toxicity (7.5) Renin-angiotensin inhibitors: Increased risk of hypotension and renal impairment. (7.7) Radiocontrast agents: Increased risk of renal toxicity. (7.8) Corticosteroids and ACTH: Increased risk of hypokalemia. (7.9) 7.1 Nonsteroidal Anti-inflammatory Drugs Because torsemide and salicylates compete for secretion by renal tubules, patients receiving high doses of salicylates may experience salicylate toxicity when torsemide is concomitantly administered. Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) and torsemide has been associated with the development of acute renal failure. The antihypertensive and diuretic effects of torsemide can be reduced by NSAIDs. Partial inhibition of the natriuretic effect of torsemide by concomitant administration of indomethacin has been demonstrated for torsemide under conditions of dietary sodium restriction (50 mEq/day) but not in the presence of normal sodium intake (150 mEq/day). 7.2 Cytochrome P450 2C9 Inhibitors and Inducers Torsemide is a substrate of CYP2C9. Concomitant use of CYP2C9 inhibitors (e.g., amiodarone, fluconazole, miconazole, oxandrolone) can decrease torsemide clearance and increase torsemide plasma concentrations. Concomitant use of CYP2C9 inducers (e.g., rifampin) increase torsemide clearance and decrease plasma torsemide concentrations. Monitor diuretic effect and blood pressure when used in combination with CYP2C9 inhibitor or inducer.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Torsemide
▾
- Allergy to torsemide or povidone: Do not take torsemide — it is contraindicated
- No urine output (anuria): Torsemide is contraindicated if your kidneys are producing no urine
- Hepatic coma: Torsemide is contraindicated in this condition
- Liver disease (cirrhosis): Use with great caution; fluid shifts can worsen liver-related brain problems; a potassium-sparing drug should be given alongside torsemide
- Kidney disease: Torsemide can still work, but reduced kidney function affects how much of the drug reaches its site of action; close monitoring is needed
- Pregnancy: No human safety data exist; high doses caused fetal harm in animals — discuss the benefits and risks with your doctor
- Breastfeeding: It is unknown whether torsemide passes into breast milk; diuretics can suppress milk production — consult your doctor
- Children: Safety and effectiveness have not been established in pediatric patients
- Older adults: Kidney clearance may be somewhat lower with age, but no specific dose adjustment was required in clinical studies; monitoring is still important
Torsemide overdose
▾
Taking too much torsemide can lead to severe dehydration, very low blood pressure, and dangerous drops in sodium, potassium, and other electrolytes. Treatment focuses on replacing fluids and correcting electrolyte levels. Torsemide cannot be removed by hemodialysis (dialysis), so prevention and supportive care are the main approaches.
What Torsemide does in the body
▾
After an oral dose, torsemide begins increasing urine output within about 1 hour, peaks in the first or second hour, and the diuretic effect lasts roughly 6 to 8 hours. It increases the urinary loss of sodium, chloride, and water without significantly affecting overall kidney filtration or the body's acid-base balance. In clinical trials, daily use significantly reduced body weight and swelling in patients with heart failure. For high blood pressure, the full blood-pressure-lowering effect takes 4 to 6 weeks and may continue to develop for up to 12 weeks.
How your body processes Torsemide
▾
Torsemide tablets are well absorbed — about 80% of the dose reaches the bloodstream, with blood levels peaking roughly 1 hour after taking a tablet. Food slightly delays that peak but does not reduce overall absorption or effectiveness. The drug is more than 99% bound to plasma proteins, and it is primarily broken down by the liver (about 80% of clearance) with the remainder excreted by the kidneys. The elimination half-life — how long it takes the body to clear half the drug — is approximately 3.5 hours in healthy adults. In people with heart failure or liver disease, clearance slows and the drug stays in the body longer, which is why careful dosing and monitoring matter in those groups.
How to store Torsemide
▾
Store at 20°C to 25°C (68°F to 77°F) . Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Keep out of reach of children.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Torsemide
251 supplements and herbal products have documented interactions with Torsemide in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 10
- Moderate · 204
- Minor · 37
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Torsemide has been associated with lower levels of 8 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 2
- Moderate · 3
- Unrated · 3
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Torsemide: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Torsemide — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is torsemide doing for me — is it just making me urinate more?
▾
When should I take torsemide — does it matter what time of day?
▾
What side effects should I just expect versus which ones mean I need to call my doctor?
▾
Are there any common medications I should be careful combining with torsemide?
▾
I have liver disease — is torsemide safe for me?
▾
Can I stop taking torsemide if I feel better or if my swelling goes away?
▾
Is Torsemide available over the counter?
▾
When was Torsemide first available?
▾
Who makes Torsemide?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Torsemide on HelloPharmacist
Torsemide forms and strengths (how it comes)
Torsemide is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Torsemide inactive ingredients by manufacturer.
Tablet
How this form is used
- Torsemide tablets are used to treat edema (fluid buildup) associated with heart failure
- Torsemide tablets are used to treat edema associated with renal disease (kidney disease)
- Torsemide tablets are used to treat edema associated with hepatic disease (liver disease)
- Torsemide tablets are used to treat high blood pressure (hypertension), alone or with other agents
- Torsemide tablets are taken by mouth once daily
- Torsemide tablets can be taken with or without food — food may slightly delay the onset but does not reduce the overall effect
- For edema related to liver disease (hepatic cirrhosis), Torsemide tablets should be taken together with an aldosterone antagonist or a potassium-sparing diuretic as directed by your doctor
- Follow your prescriber's instructions for dose adjustments; do not change your dose on your own
Torsemide on the U.S. market: products, makers and brands
How Torsemide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
21 companies list 62 Torsemide product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1993. Brand names on the directory include Demadex, Soaanz, Upcard; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (12) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Torsemide is used (Medicaid data)
A general measure of how commonly Torsemide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Torsemide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Torsemide prescribed? Of the 1,601 medications we measure, Torsemide ranks #322 by Medicaid prescriptions — more than 80% of them.
Utilization by Torsemide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
torsemide 20 MG Oral Tablet Most dispensed
Summed across the 10 of 56 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198371
torsemide 10 MG Oral Tablet
Summed across the 4 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198369
torsemide 100 MG Oral Tablet
Summed across the 5 of 21 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198370
torsemide 5 MG Oral Tablet
Summed across the 4 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 198372
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Torsemide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 23 of 123 listed Torsemide NDCs with Medicaid activity.
Compare Torsemide products
A representative set of FDA-listed product records for Torsemide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 20 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 20 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 10 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 20 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 100 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 5 mg | Oral | AvKARE | ANDA | View NDC → |
| 10 mg | Oral | AvKARE | ANDA | View NDC → |
| 20 mg | Oral | AvKARE | ANDA | View NDC → |
| 100 mg | Oral | AvKARE | ANDA | View NDC → |
| 5 mg | Oral | AvPAK | ANDA | View NDC → |
| 10 mg | Oral | AvPAK | ANDA | View NDC → |
| 20 mg | Oral | AvPAK | ANDA | View NDC → |
| 100 mg | Oral | AvPAK | ANDA | View NDC → |
| 10 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 5 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 10 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 20 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 100 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 10 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 5 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 20 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 10 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 20 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 20 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 20 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Sarfez Pharmaceuticals Inc | NDA | View NDC → |
| 5 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 5 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 20 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 100 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
Showing 62 of 62 products — FDA National Drug Code Directory. See every product, package size and price: browse all 62 Torsemide NDCs →
Torsemide side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Torsemide — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Torsemide are dyspnoea, fatigue, diarrhoea; about 81% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Torsemide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Torsemide FDA approval history
How Torsemide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Torsemide was first approved by the FDA in 1993 (Brand: DEMADEX · Roche); the first generic version was approved in 2002. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Torsemide recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Torsemide recalls since July 2021.
✅No Torsemide recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 38413 2 dose forms · 8 strengths
-
Dose form (SCDF) Oral Solution RxCUI 2682554No current FDA listingClinical drug / strength (SCD) 2 MG/MLRxCUI 2682555 -
Dose form (SCDF) Oral Tablet RxCUI 374168In current FDA listings
Look up RxCUI 38413 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Torsemide supply and shortage status
Whether Torsemide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Torsemide costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 20 mg | $0.064 per tablet | NDC details & price history |
| Tablet · Oral | 100 mg | $0.174 per tablet | NDC details & price history |
| Tablet · Oral | 5 mg | $0.057 per tablet | NDC details & price history |
| Tablet | 5 mg | $0.057 per tablet | NDC details & price history |
| Tablet | 10 mg | $0.066 per tablet | NDC details & price history |
| Tablet | 20 mg | $0.064 per tablet | NDC details & price history |
| Tablet | 100 mg | $0.174 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Torsemide brand names
Torsemide is sold under 3 brand names in the FDA directory — Demadex, Soaanz, Upcard. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Torsemide: manufacturers and labelers
21 companies list Torsemide products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, A-S Medication Solutions, Aurobindo Pharma Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Torsemide drug class (RxNorm)
Torsemide belongs to the Loop Diuretic class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Torsemide page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Sarfez Pharmaceuticals Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →